Private Sector Will Be Key Source Of Data To Inform Value-Based Coverage Decisions – Former Merck Exec Spatz
Executive Summary
New data, not just an analysis of existing data, is needed to achieve the goals of getting the most value out of money spent on health care.
You may also be interested in...
Big Data Transforming The Role Of Pharma, IBM Analytics Partner Says
Pharmaceutical companies are beginning to leverage big data to become more integrated into health care delivery, looking to care coordination and other “services adjacent to medicines,” IBM’s John Piccone reports.
Payers’ Use Of Real-World Evidence For Drug Coverage On The Rise – IMS Health
A new study by IMS Health shows payers globally are making more drug reimbursement decisions based on real-world evidence – including 25% of more than 100 identified case studies using biopharma industry-generated data.
CMS Sets The Stage For New Medicare "Coverage With Evidence Development" Guidance
A rarely-used tool for gathering data on medical technologies will get a fresh look as the agency solicits public comment on how to make CED a more meaningful and effective part of its coverage decision-making process.